Literature DB >> 22966040

Global effect of interleukin-10 on the transcriptional profile induced by Neisseria meningitidis in human monocytes.

Unni Gopinathan1, Reidun Ovstebø, Ole Kristoffer Olstad, Berit Brusletto, Hans Christian Dalsbotten Aass, Peter Kierulf, Petter Brandtzaeg, Jens Petter Berg.   

Abstract

In meningococcal septic shock, the dominant inducer of inflammation is lipopolysaccharide (LPS) in the outer membrane of Neisseria meningitidis, while interleukin-10 (IL-10) is the principal anti-inflammatory cytokine. We have used microarrays and Ingenuity Pathway Analysis to study the global effects of IL-10 on gene expression induced by N. meningitidis, after exposure of human monocytes (n = 5) for 3 h to N. meningitidis (10(6) cells/ml), recombinant human IL-10 (rhIL-10) (25 ng/ml), and N. meningitidis combined with rhIL-10. N. meningitidis and IL-10 differentially expressed 3,579 and 648 genes, respectively. IL-10 downregulated 125 genes which were upregulated by N. meningitidis, including NLRP3, the key molecule of the NLRP3 inflammasome. IL-10 also upregulated 270 genes which were downregulated by N. meningitidis, including members of the leukocyte immunuglobulin-like receptor (LIR) family. Fifty-three genes revealed a synergistically increased expression when N. meningitidis and IL-10 were combined. AIM2 (the principal molecule of the AIM2 inflammasome) was among these genes (fold change [FC], 18.3 versus 7.4 and 9.4 after stimulation by N. meningitidis and IL-10, respectively). We detected reduced concentrations (92% to 40%) of six cytokines (IL-1b, IL-6, IL-8, tumor necrosis factor alpha [TNF-α], macrophage inflammatory protein alpha [MIP-α], MIP-β) in the presence of IL-10, compared with concentrations with stimulation by N. meningitidis alone. Our data analysis of the effects of IL-10 on gene expression induced by N. meningitidis suggests that high plasma levels of IL-10 in meningococcal septic shock plasma may have a profound effect on a variety of functions and cellular processes in human monocytes, including cell-to-cell signaling, cellular movement, cellular development, antigen presentation, and cell death.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22966040      PMCID: PMC3486056          DOI: 10.1128/IAI.00386-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Shaping gene expression in activated and resting primary macrophages by IL-10.

Authors:  Roland Lang; Divyen Patel; John J Morris; Robert L Rutschman; Peter J Murray
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

Review 3.  Neisseria meningitidis lipopolysaccharides in human pathology.

Authors:  P Brandtzaeg; A Bjerre; R Øvstebø; B Brusletto; G B Joø; P Kierulf
Journal:  J Endotoxin Res       Date:  2001

Review 4.  The inflammasome: an integrated view.

Authors:  Olaf Gross; Christina J Thomas; Greta Guarda; Jurg Tschopp
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 5.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  IL-10 expression profiling in human monocytes.

Authors:  Lynn Williams; Gabor Jarai; Alexandra Smith; Peter Finan
Journal:  J Leukoc Biol       Date:  2002-10       Impact factor: 4.962

7.  Involvement of receptor-interacting protein 2 in innate and adaptive immune responses.

Authors:  Arnold I Chin; Paul W Dempsey; Kevin Bruhn; Jeff F Miller; Yang Xu; Genhong Cheng
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

8.  Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.

Authors:  Anna Bjerre; Berit Brusletto; Reidun Øvstebø; Gun Britt Joø; Peter Kierulf; Petter Brandtzaeg
Journal:  J Endotoxin Res       Date:  2003

Review 9.  Interleukin-10 therapy--review of a new approach.

Authors:  K Asadullah; W Sterry; H D Volk
Journal:  Pharmacol Rev       Date:  2003-06       Impact factor: 25.468

10.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

Authors:  Fabio Martinon; Kimberly Burns; Jürg Tschopp
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

View more
  10 in total

1.  CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.

Authors:  Andrew D Vonberg; Maria Acevedo-Calado; Aaron R Cox; Susan L Pietropaolo; Roberto Gianani; Steven K Lundy; Massimo Pietropaolo
Journal:  JCI Insight       Date:  2018-12-06

2.  Haemophilus ducreyi infection induces activation of the NLRP3 inflammasome in nonpolarized but not in polarized human macrophages.

Authors:  Wei Li; Barry P Katz; Margaret E Bauer; Stanley M Spinola
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

3.  Large-scale reduction of tyrosine kinase activities in human monocytes stimulated in vitro with N. meningitidis.

Authors:  Unni Gopinathan; Kathrine Røe Redalen; Anne-Marie Trøseid; Peter Kierulf; Petter Brandtzaeg; Anne Hansen Ree; Jens Petter Berg; Reidun Øvstebø
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

4.  Transcriptomic data from two primary cell models stimulating human monocytes suggest inhibition of oxidative phosphorylation and mitochondrial function by N. meningitidis which is partially up-regulated by IL-10.

Authors:  Unni Gopinathan; Reidun Øvstebø; Berit Sletbakk Brusletto; Ole Kristoffer Olstad; Peter Kierulf; Petter Brandtzaeg; Jens Petter Berg
Journal:  BMC Immunol       Date:  2017-10-27       Impact factor: 3.615

5.  Traceability and distribution of Neisseria meningitidis DNA in archived post mortem tissue samples from patients with systemic meningococcal disease.

Authors:  Berit Sletbakk Brusletto; Bernt Christian Hellerud; Else Marit Løberg; Ingeborg Løstegaard Goverud; Åshild Vege; Jens Petter Berg; Petter Brandtzaeg; Reidun Øvstebø
Journal:  BMC Clin Pathol       Date:  2017-08-16

6.  Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsis.

Authors:  Bernt C Hellerud; Hilde L Orrem; Knut Dybwik; Søren E Pischke; Andreas Baratt-Due; Albert Castellheim; Hilde Fure; Grethe Bergseth; Dorte Christiansen; Miles A Nunn; Terje Espevik; Corinna Lau; Petter Brandtzæg; Erik W Nielsen; Tom E Mollnes
Journal:  J Intensive Care       Date:  2017-02-27

7.  Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2.

Authors:  Subhankar Mukhopadhyay; Eva Heinz; Immacolata Porreca; Kaur Alasoo; Amy Yeung; Huei-Ting Yang; Tobias Schwerd; Jessica L Forbester; Christine Hale; Chukwuma A Agu; Yoon Ha Choi; Julia Rodrigues; Melania Capitani; Luke Jostins-Dean; David C Thomas; Simon Travis; Daniel Gaffney; William C Skarnes; Nicholas Thomson; Holm H Uhlig; Gordon Dougan; Fiona Powrie
Journal:  J Exp Med       Date:  2020-02-03       Impact factor: 14.307

8.  Transcriptomic changes in the large organs in lethal meningococcal shock are reflected in a porcine shock model.

Authors:  Berit Sletbakk Brusletto; Bernt Christian Hellerud; Ole Kristoffer Olstad; Reidun Øvstebø; Petter Brandtzaeg
Journal:  Front Cell Infect Microbiol       Date:  2022-08-11       Impact factor: 6.073

9.  Human hepatocytes express absent in melanoma 2 and respond to hepatitis B virus with interleukin-18 expression.

Authors:  Xingfei Pan; Haixia Xu; Changlong Zheng; Mei Li; Xiaofang Zou; Hong Cao; Qihuan Xu
Journal:  Virus Genes       Date:  2016-04-19       Impact factor: 2.198

10.  Extensive Changes in Transcriptomic "Fingerprints" and Immunological Cells in the Large Organs of Patients Dying of Acute Septic Shock and Multiple Organ Failure Caused by Neisseria meningitidis.

Authors:  Berit Sletbakk Brusletto; Else Marit Løberg; Bernt Christian Hellerud; Ingeborg Løstegaard Goverud; Jens Petter Berg; Ole Kristoffer Olstad; Unni Gopinathan; Petter Brandtzaeg; Reidun Øvstebø
Journal:  Front Cell Infect Microbiol       Date:  2020-02-19       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.